Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Novartis Pharma

This page shows the latest Novartis Pharma news and features for those working in and with pharma, biotech and healthcare.

Novartis negotiates ex-US rights to Spark gene therapy

Novartis negotiates ex-US rights to Spark gene therapy

Novartis negotiates ex-US rights to Spark gene therapy. Strikes $170m deal for Luxturna. ... This collaboration builds on our commitment to ophthalmology, ”commented Shreeram Aradhye, chief medical officer at Novartis Pharma, adding that there is

Latest news

  • Pharma’s digital patient engagement innovators identified Pharma’s digital patient engagement innovators identified

    Pharma’ s digital patient engagement innovators identified. Novartis, Pfizer and Sanofi named best-in-class by Decision Resources Group. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

  • Novartis moves swiftly with lymphoma filing for CAR-T Kymriah Novartis moves swiftly with lymphoma filing for CAR-T Kymriah

    Novartis moves swiftly with lymphoma filing for CAR-T Kymriah. Will go up against Kite Pharma's Yescarta if approved. ... Approval for DLBCL will up the ante in Novartis’rivalry with CAR-T developer Kite Pharma - now part of Gilead Sciences - which got

  • Novartis to buy French radiopharma specialist AAA for $3.9bn Novartis to buy French radiopharma specialist AAA for $3.9bn

    Novartis to buy French radiopharma specialist AAA for $3.9bn. Deal will strengthen its cancer therapy business, says Swiss pharma group. ... The first patient was recently treated with the drug in Japan, where it is partnered with Fujifilm RI Pharma.

  • Breathing data Breathing data

    Undifferentiated, unspecialised business models will be outcompeted by new models. Novartis and our other leading companies are led by very smart people. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and

  • Novartis looks outside pharma for digital transformation Novartis looks outside pharma for digital transformation

    Novartis looks outside pharma for digital transformation. Appoints former Sainsbury's Argos executive Bertrand Bodson. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

More from news
Approximately 6 fully matching, plus 141 partially matching documents found.

Latest Intelligence

  • Can value-based healthcare take off and reach for the skies? Can value-based healthcare take off and reach for the skies?

    they do badly, ”added Mr Moran, who joined Novartis from McKinsey &Company as a strategic assistant to the CEO in January 2015. ... A one-off treatment, it comes with the hefty $475, 000 price tag - and a red rag to anti-pharma factions - but put

  • Bridging pharma’s digital gap Bridging pharma’s digital gap

    But in true pharma fashion, that leap was not without its side effects. ... What Novartis and all the other pharma companies are trying to do is distil the myriad content that they have available at their fingertips and transform it into something useful,

  • Are we #winning? Are we #winning?

    We’ve seen multiple online ‘TV’channels launch from medical societies and congress; some (eg ASCO) have commoditised their assets, and - for example, with Novartis’VivindaTV.com - pharma is now competing ... As this transformation continues at

  • Deal Watch December 2016 Deal Watch December 2016

    295. Novartis (Switzerland). Sun Pharma (India). Asset acquisition. Odomzo (sonidegib; hedgehog pathway inhibitor), approved in basal cell carcinoma. ... and Bicycle Therapeutics at $1bn, and the Purdue Pharma-Exicure deal, at $790m.

  • Deal Watch November 2016 Deal Watch November 2016

    Deal Watch November 2016. Actelion, Allergan, Johnson &Johnson, Novartis and more feature in this month's pharma deals round-up. ... As Juno wrestles with bad publicity and a depressed share price, Novartis and Kite Pharma, also active in the CAR T cell

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Eric Cornut appointed EFPIA interim director general Eric Cornut appointed EFPIA interim director general

    He most recently served as chief ethics, compliance and policy officer at Novartis, taking up the position in 2014 after a four-year stint as chairman of the board for Novartis ... Japan. Having first joined Novartis in 1997 as a general manager in The

  • UCB CEO elected to the Ministerial Industry Strategy Group UCB CEO elected to the Ministerial Industry Strategy Group

    Tellier was elected by member of the European Medicines Group (EMG) and will act as group representative for the European pharma companies. ... Tellier joined UCB in 2011 as an executive VP after serving as president of Ipsen, North America, and CEO of

  • Coulter Partners names head of Swiss office Coulter Partners names head of Swiss office

    Ernberg has had a varied career spending time at press agency Reuters, pharma company Novartis and humanitarian firm Vestergaard Frandsen.

  • Boehringer Ingelheim promotes Debraj Dasgupta Boehringer Ingelheim promotes Debraj Dasgupta

    Since joining the German pharma company in 2013 Dasgupta has oversaw customer insights across multiple therapy areas, including oncology, metabolism and immunology. ... Prior to this he spent nine years at Novartis in Switzerland where he led a number of

  • Alcon names president EMEA Alcon names president EMEA

    Dr Riad Sherif has left his role at Novartis in Canada to join the pharma giant's eyecare business Alcon as president for the EMEA region. ... He now heads the EMEA region for Alcon, which is the global leader in eyecare and is the second largest

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Experienced Healthcare Marketer Gareth Thurston, joins Cello Health Consulting

    Gareth has over 20 years’ experience in senior roles in a number of pharma companies, most recently at Novartis, where he spent seven years in various roles, including Brand Lead Opthalmology, ... biggest pharma companies.” Gareth will be based at

  • Marketing strategy in complex environments

    Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines. ... The last few years have seen influential scientific advances, resulting in subtle shifts in how pharma tackles disease treatment.

  • How do you define a biotech company?

    Johnson &Johnson and Pfizer are two of the largest pharma companies in the world by revenue but both have numerous biological therapies. ... This approach is particularly apparent in some of the recent examples of technology pioneered by biotech

  • GEM Marketing Ltd

    Our clients include:. AbbVie. Amgen. Gilead. Martindale Pharma. Menarini. Merck. Novartis.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Quick links

Infographics

Multimedia